News & Updates
Filter by Specialty:
Varenicline nasal spray improves bilateral tear production in dry eye disease
Treatment with OC-01 (varenicline solution) nasal spray in patients with dry eye results in a substantial increase in tear production in the study eyes as well as in milder presenting nonstudy fellow eyes, according to data from the ONSET-1* and ONSET-2 trials.
Varenicline nasal spray improves bilateral tear production in dry eye disease
07 Nov 2022Statin use linked to reduced risk of severe COVID-19 outcomes
Patients who are on long-term statin therapy may have a reduced risk of severe COVID-19–related outcomes including mortality, intensive care unit (ICU) admission, and requirement for mechanical ventilation, according to a study presented at Anesthesiology 2022.
Statin use linked to reduced risk of severe COVID-19 outcomes
06 Nov 2022Third-dose vaccine beats tolerance in cirrhotic COVID-19 patients
A third-dose administration of a COVID-19 mRNA vaccine results in a more substantial decrease in COVID-19 in patients with cirrhosis compared with the general population, according to a study. This suggests that the third dose can overcome vaccine hyporesponsiveness in this population.
Third-dose vaccine beats tolerance in cirrhotic COVID-19 patients
06 Nov 2022COSMIC-313: Adding cabozantinib to nivo-ipi may improve PFS in advanced RCC
The combination of nivolumab, ipilimumab, and cabozantinib improved progression-free survival (PFS) in patients with previously untreated, advanced renal cell carcinoma (RCC) of intermediate or poor risk as per IMDC* criteria, results of the phase III COSMIC-313 trial showed.